188 related articles for article (PubMed ID: 35500249)
1. Randomized trial of the efficacy of trial-based cognitive therapy for obsessive-compulsive disorder: preliminary findings.
Rodrigues EP; Fechine AJB; Oliveira AC; Matos CFF; Passarela CM; Hemanny C; Dias FM; Batista JW; Albuquerque LCN; Soares MS; Coelho PE; Araújo VPC; Ayres ZM; de Oliveira IR
Trends Psychiatry Psychother; 2023; 45():e20210247. PubMed ID: 35500249
[TBL] [Abstract][Full Text] [Related]
2. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
[TBL] [Abstract][Full Text] [Related]
3. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
4. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
5. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
Rector NA; Richter MA; Katz D; Leybman M
Br J Clin Psychol; 2019 Mar; 58(1):1-18. PubMed ID: 29984550
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled study of brief family-based intervention in obsessive compulsive disorder.
Baruah U; Pandian RD; Narayanaswamy JC; Bada Math S; Kandavel T; Reddy YCJ
J Affect Disord; 2018 Jan; 225():137-146. PubMed ID: 28829958
[TBL] [Abstract][Full Text] [Related]
7. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
8. Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial.
Kyrios M; Ahern C; Fassnacht DB; Nedeljkovic M; Moulding R; Meyer D
J Med Internet Res; 2018 Aug; 20(8):e242. PubMed ID: 30089607
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
10. Personalized exposure and experience sampling method feedback versus exposure as usual for obsessive-compulsive disorder: a study protocol for a randomized controlled trial.
Hoogerwerf E; Greeven A; Goekoop R; Spinhoven P
Trials; 2024 Jan; 25(1):43. PubMed ID: 38217045
[TBL] [Abstract][Full Text] [Related]
11. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
12. Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial.
Franklin ME; Kozak MJ; Cashman LA; Coles ME; Rheingold AA; Foa EB
J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):412-9. PubMed ID: 9549962
[TBL] [Abstract][Full Text] [Related]
13. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
14. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
[TBL] [Abstract][Full Text] [Related]
15. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
Fineberg NA; Baldwin DS; Drummond LM; Wyatt S; Hanson J; Gopi S; Kaur S; Reid J; Marwah V; Sachdev RA; Pampaloni I; Shahper S; Varlakova Y; Mpavaenda D; Manson C; O'Leary C; Irvine K; Monji-Patel D; Shodunke A; Dyer T; Dymond A; Barton G; Wellsted D
Int Clin Psychopharmacol; 2018 Nov; 33(6):334-348. PubMed ID: 30113928
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
[TBL] [Abstract][Full Text] [Related]
17. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
Albert U; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
[TBL] [Abstract][Full Text] [Related]
18. Commonly asked questions in the treatment of obsessive-compulsive disorder.
Arumugham SS; Reddy YC
Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
Franklin ME; Sapyta J; Freeman JB; Khanna M; Compton S; Almirall D; Moore P; Choate-Summers M; Garcia A; Edson AL; Foa EB; March JS
JAMA; 2011 Sep; 306(11):1224-32. PubMed ID: 21934055
[TBL] [Abstract][Full Text] [Related]
20. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis.
Ivarsson T; Skarphedinsson G; Kornør H; Axelsdottir B; Biedilæ S; Heyman I; Asbahr F; Thomsen PH; Fineberg N; March J;
Psychiatry Res; 2015 May; 227(1):93-103. PubMed ID: 25769521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]